Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Early life body size, growth and risks of systemic lupus erythematosus - A large Danish observational cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Glucocorticoid-trials in rheumatoid arthritis mostly study representative real-world patients: A systematic review and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
To summarize the empirical evidence regarding the effect of treatment intensification on clinical outcomes in patients with rheumatoid arthritis treated with one of the TNF-α-inhibitors, adalimumab, etanercept or infliximab.
Original languageEnglish
JournalSeminars in Arthritis and Rheumatism
Volume43
Issue number2
Pages (from-to)144-51
Number of pages8
ISSN0049-0172
DOIs
Publication statusPublished - Oct 2013

ID: 42570271